Several possible reasons for the lack of efficacy of antioxidants in clinical trials include (i) insufficient antioxidant levels in the target organ, especially in the nervous system, because an integrated bloodbrain barrier (BBB) is a major obstacle to delivering desired substances, including antioxidants, into the CNS
Treatment success should be defined not only by weight loss but also by improvements in comorbidities, quality of life, and prevention of further weight gain
About this article Cite this article Gwyer, D., Wragg, N.M
n-3 fatty acids and cardiovascular events after myocardial infarction
Comparative analysis of cancer risk among glucose-lowering agents Current clinical evidence indicates that various classes of antidiabetic drugs show substantial variability in their association with cancer risk
NCM is thought to arise from the aberrant proliferation of neural crest-derived melanocytes